ClinicalTrials.gg
Not yet recruitingNCT07115381Updated Dec 30, 2025

A Study on the Intervention Effect of Therapeutic Horticulture Based on the Healing System on Non-suicidal Self-injury in Adolescent Patients With Depression

An interventional study of Therapeutic Horticulture and Routine treatment and nursing in Depression, sponsored by Lei Huang. Not yet recruiting at 1 site in China. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-30.

Sponsored by Lei Huang · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 358 studies in Depression with a site in China — 119 open to participants now, 138 under way, 3 of them phase 3. Depression · China.

Planned enrollment
205th of 284
66 · median 129
Started
2026
with 37 others
No phase
218 of 358
71 open now
Primary completion
2026-12
later than 79 of 137 live
Registered
290th of 358
by date

Among the 358 studies in Depression with a site in China, this one is the 205th largest by planned enrollment of the 284 interventional ones that give a count, is one of 38 that started in 2026, is one of 218 with no phase, reaches primary completion later than 79 of the 137 other live ones, and was the 290th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

119 of the 358 studies in Depression with a site in China are open now. Recruiting first, the newest first:

114 more — sign in →

All 119 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 358 studies in Depression with a site in China, or all of them as a file.
02

Study summary

Non-suicidal self-harm is a serious issue. Adolescents with depression are among the high-risk groups for non-suicidal self-harm behavior. Therapeutic gardening uses plant cultivation and corresponding gardening activities as the medium of action, allowing patients to obtain therapeutic benefits by participating in gardening activities such as planting, maintaining, and harvesting plants. Therefore, this study will apply therapeutic gardening based on the healing system to adolescents with depression who have non-suicidal self-harm behavior, in order to improve their non-suicidal self-harm behavior, negative emotions, emotional expression disorders, self-efficacy, sleep quality, and loneliness.

Read the detailed description

Based on the theories of positive psychology and the healing system theory framework, referring to relevant domestic and foreign literature and consulting books such as "Introduction to Horticultural Therapy", "Horticultural Rehabilitation Therapy Techniques", and "Horticultural Therapy: Growing Good Health for the Body and Mind", an intervention plan was formulated under the guidance of experts. A randomized controlled trial design was adopted. It is planned to carry out therapeutic horticulture based on the healing system for adolescent patients with depression who have non-suicidal self-harming behaviors, according to the intervention plan. By evaluating and comparing the changes and differences in indicators such as non-suicidal self-harming behaviors, emotions, physical functions, skills, and social interaction of the experimental group and the control group before and after the intervention, the actual effect of therapeutic horticulture based on the healing system in reducing the occurrence of non-suicidal self-harming behaviors among adolescent patients was verified. Finally, data analysis and paper writing were conducted.

03

Conditions studied

  • Depression

Browse trials for

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • It meets the diagnostic criteria for moderate to severe depression in the Fifth Edition of the (DSM-5).
  • It meets the diagnostic criteria for non-suicidal self-harm in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
  • The patients and their guardians gave and voluntarily participated in this study.
  • Have normal reading comprehension ability, language communication ability and writing ability.

Exclusion criteria

Exclusion Criteria:

  • Include mental disorders such as mental retardation, autism spectrum disorder, stereotyped movement disorder with self-harm, etc.
  • Have had or currently have central nervous system diseases, endocrine system diseases, and other serious physical disorders.
  • Are currently receiving or have received any form of systematic horticultural therapy within the past 3 months.
  • Have allergic reactions to pollen, soil, or other substances that may be encountered during the intervention process.
  • Have a risk of suicide and suicidal behavior.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Other
    Control group

    Routine treatment and nursing

    Other: Routine treatment and nursing

  • Experimental
    Therapeutic Horticulture group

    Routine treatment and nursing and Therapeutic Horticulture

    Behavioral: Therapeutic Horticulture · Other: Routine treatment and nursing

Interventions

  • BehavioralTherapeutic Horticulture

    Therapeutic Horticulture uses plant cultivation and related gardening activities as the medium of action, allowing patients to participate in gardening activities such as planting, maintenance, and harvesting of plants.

  • OtherRoutine treatment and nursing

    The conventional treatment mainly involves the use of antidepressant drugs, supplemented by physical therapy, psychological therapy, and rehabilitation training, etc. The routine care includes admission introduction, health education (manifestations, hazards, treatment methods of depression and non-suicidal self-harm, as well as the importance of following medical advice for treatment), medication guidance, discharge guidance, and psychological care, etc.

06

What researchers measure

Primary outcomes

  1. The level and frequency of non-suicidal self-injury

    The adolescent self-harm questionnaire was used to measure.This questionnaire is a self-assessment form, consisting of 19 items. Among them, the frequency of non-suicidal self-injury behavior is scored using the Likert 4-point scale: "0 times" is scored 0 points, "1 time" is scored 1 point, "2-4 times" is scored 2 points, and "5 times or more" is scored 3 points. The degree of physical harm caused is scored using the Likert 5-point scale: "No" is scored 0 points, "Mild" is scored 1 point, "Moderate" is scored 2 points, "Severe" is scored 3 points, and "Extremely severe" is scored 4 points. NSSI equivalence is equal to the product of the NSSI frequency score and the NSSI severity score. The higher the score, the more severe the condition.

    Time frame: Day 1 and Day 14

Secondary outcomes

  1. depressive symptom

    Hamilton Depression Rating Scale-17 was used to measure.There are a total of 17 items. The lowest score of the Hamilton Depression Scale - 17 items (HAMD-17) is 0, and the highest score is 52. A total score of ≥ 24 may indicate severe depression; a score of 17 ≤ total score \< 24 may indicate mild or moderate depression; a total score of ≤ 7 may indicate no depression. The higher the score, the more severe the depressive symptoms.

    Time frame: Day 1 and Day 14

  2. sleep quality

    The Pittsburgh Sleep Quality Index was used to measure.This scale is used to assess an individual's recent sleep quality. It consists of 19 self-assessment items and 5 other-rater items. The 19th self-assessment item and the 5 other-rater items do not contribute to the scoring. The first 18 items cover subjective sleep quality, sleep onset time, sleep duration, sleep efficiency, sleep disorders, hypnotic drugs, and daytime functional impairment. Each factor is scored on a scale of 0 to 3, and the total score of all factors is the PSQI total score. The total score ranges from 0 to 21, and a higher PSQI total score indicates poorer sleep quality.

    Time frame: Day 1 and Day 14

  3. alexithymia

    The Toronto Alexithymia Scale was used to measure.The scale consists of 20 items, including three factors: inability to identify emotions, inability to describe emotions, and extroverted thinking. It uses a 5-point scale from 1 (completely disagree) to 5 (completely agree), with a total score range of 20 to 100. The higher the score, the more severe the alexithymia is.

    Time frame: Day 1 and Day 14

  4. loneliness

    The UCLA loneliness Scale was used to measure.This scale is used to assess an individual's level of loneliness, consisting of 20 items, with a 4-point rating scale ranging from 1 to 4. Some of the items are reverse-scored. The total score is the sum of the scores of each item. The total score ranges from 20 to 80, with a higher total score indicating a stronger sense of loneliness.

    Time frame: Day 1 and Day 14

  5. self-efficacy

    The general self-efficacy scale was used to measure.This scale consists of 10 items. It uses a 4-point rating system, where "completely incorrect" is scored as 1 point, "somewhat correct" as 2 points, "mostly correct" as 3 points, and "completely correct" as 4 points. The highest score is 40 points and the lowest score is 10 points. The higher the score, the higher the level of self-efficacy.

    Time frame: Day 1 and Day 14

07

Study locations

1 site
08

References and documents

Publications

  • Huang L, Hong TD, Liang SC, Huang ZJ, Liang YX, Shen LF, Xia ZC. The effect of therapeutic horticulture on non-suicidal self-injury in adolescents with major depressive disorder: protocol for a randomized controlled trial. Front Psychiatry. 2026 Jun 4;17:1790759. doi: 10.3389/fpsyt.2026.1790759. eCollection 2026. PubMed 42325965 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Dec 2026, 10 months later.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 10 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2025
First posted
Aug 11, 2025
StartEst.
Feb 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Dec 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07115381
Lead sponsor
Lei Huang
Responsible party
Lei Huang (nurse, Guangzhou Medical University) — Sponsor-investigator
First posted
Aug 11, 2025
Start date
Feb 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 30, 2025

Study contacts

Lei Huang, bachelor degree
Contact
huanglei8126@163.com
0086-13660135023
Zhichun Xia
study director · The Affiliated Brain Hospital of Guangzhou Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion